These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30187175)

  • 21. Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
    Yue Q; Yu Y; Shi Z; Wang Y; Zhu W; Du Z; Yao Z; Chen L; Mao Y
    J Neurosurg; 2018 Jul; 129(1):27-34. PubMed ID: 28984520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas-differences in mutation profiles in epithelial-derived oropharyngeal neoplasms.
    Bartels S; Adisa A; Aladelusi T; Lemound J; Stucki-Koch A; Hussein S; Kreipe H; Hartmann C; Lehmann U; Hussein K
    Virchows Arch; 2018 Jun; 472(6):1055-1059. PubMed ID: 29546640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature.
    Losa M; Mazza E; Pedone E; Nocera G; Liscia N; Reni M; Mortini P
    J Endocrinol Invest; 2024 Nov; 47(11):2835-2842. PubMed ID: 38696125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors.
    Roque A; Odia Y
    CNS Oncol; 2017 Apr; 6(2):95-99. PubMed ID: 28425764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of outcomes following craniotomy and expanded endoscopic endonasal transsphenoidal resection of craniopharyngioma and related tumors: a single-institution study.
    Jeswani S; Nuño M; Wu A; Bonert V; Carmichael JD; Black KL; Chu R; King W; Mamelak AN
    J Neurosurg; 2016 Mar; 124(3):627-38. PubMed ID: 26361276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
    Erfurth EM
    J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
    Goschzik T; Gessi M; Dreschmann V; Gebhardt U; Wang L; Yamaguchi S; Wheeler DA; Lauriola L; Lau CC; Müller HL; Pietsch T
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):126-134. PubMed ID: 28069929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.
    Prieto R; Pascual JM
    Pituitary; 2018 Aug; 21(4):431-442. PubMed ID: 29700680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.
    Mukada N; Tosaka M; Matsumura N; Yamaguchi R; Aihara M; Isoda K; Higuchi T; Tsushima Y; Yokoo H; Yoshimoto Y
    Sci Rep; 2021 Jan; 11(1):126. PubMed ID: 33420213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Craniopharyngiomas: A clinicopathological and molecular study of 52 cases - Experience in the Complejo Hospitalario de Toledo and Hospital Universitario 12 de Octubre (Madrid).
    Moreno-Torres B; Campos-Martín Y; Meléndez B; Garcia Martin RM; Vicente A; Rodríguez de Lope Á; Alen JF; Mollejo M; Hernández-Laín A
    Clin Neuropathol; 2021; 40(1):26-35. PubMed ID: 33040839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas.
    Zoli M; Sambati L; Milanese L; Foschi M; Faustini-Fustini M; Marucci G; de Biase D; Tallini G; Cecere A; Mignani F; Sturiale C; Frank G; Pasquini E; Cortelli P; Mazzatenta D; Provini F
    Neurosurg Focus; 2016 Dec; 41(6):E12. PubMed ID: 27903128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.
    Brastianos PK; Santagata S
    Eur J Endocrinol; 2016 Apr; 174(4):R139-44. PubMed ID: 26563980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients.
    Fan J; Liu Y; Pan J; Peng Y; Peng J; Bao Y; Nie J; Wang C; Qiu B; Qi S
    J Neurosurg; 2021 Nov; 135(5):1298-1309. PubMed ID: 33668037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm.
    Calvanese F; Jacquesson T; Manet R; Vasiljevic A; Lasolle H; Ducray F; Raverot G; Jouanneau E
    Front Endocrinol (Lausanne); 2022; 13():882381. PubMed ID: 35757402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes in transcranial microsurgery versus extended endoscopic endonasal approach for primary resection of adult craniopharyngiomas.
    Wannemuehler TJ; Rubel KE; Hendricks BK; Ting JY; Payner TD; Shah MV; Cohen-Gadol AA
    Neurosurg Focus; 2016 Dec; 41(6):E6. PubMed ID: 27903125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma.
    Lin AL; Tabar V; Young RJ; Geer EB
    Pituitary; 2023 Aug; 26(4):482-487. PubMed ID: 37428397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features and BRAF
    Huo Z; Lu T; Liang Z; Ping F; Shen J; Lu J; Ma W; Zhao D; Zhong D
    Diagn Pathol; 2016 Oct; 11(1):100. PubMed ID: 27760550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.
    Juratli TA; Jones PS; Wang N; Subramanian M; Aylwin SJB; Odia Y; Rostami E; Gudjonsson O; Shaw BL; Cahill DP; Galanis E; Barker FG; Santagata S; Brastianos PK
    Cancer; 2019 Sep; 125(17):2910-2914. PubMed ID: 31314136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas.
    Cavallo LM; Prevedello DM; Solari D; Gardner PA; Esposito F; Snyderman CH; Carrau RL; Kassam AB; Cappabianca P
    J Neurosurg; 2009 Sep; 111(3):578-89. PubMed ID: 19326977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Full View of Papillary Craniopharyngioma Based on Expanded Endonasal Approach: A Comprehensive Clinical Characterization of 101 Cases.
    Jia Y; Cai K; Qiao N; Liu F; Wu W; Ru S; Xiao Y; Cao L; Gui S
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.